Maryland Center for MS

Baltimore, Maryland 21201

0 studies enrolling now · 7 studies all time

What they study most

Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Study of Oral Fampridine-SR in Multiple Sclerosis — Completed
• Study of Fampridine-SR Tablets in Multiple Sclerosis Patients — Completed
• Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial — Completed
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis — Completed